Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192805 | SCV000248660 | benign | not specified | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317703 | SCV000850699 | likely benign | Inborn genetic diseases | 2020-03-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics Inc | RCV000992741 | SCV001145251 | benign | not provided | 2018-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000992741 | SCV001885872 | benign | not provided | 2019-09-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000992741 | SCV002354284 | likely benign | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003907702 | SCV004720389 | likely benign | RAI1-related condition | 2020-02-07 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |